baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ASOS PLC/ GB0030927254 /

2024-11-13 5:02:53 PM	Chg. -0.90	Volume	Bid5:30:00 PM	Ask5:30:00 PM	High	Low
359.70GBX	-0.25%	10,170 Turnover(GBP): 36,690.1690	-Bid Size: -	-Ask Size: -	364.00	357.60

GlobeNewswire 08-29 Researchers call for individualized gene therapies to be more widely accessible

GlobeNewswire 08-14 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 08-14 Denali Therapeutics Announces Publication in Science Translational Medicine Demonstrating the Potent...

GlobeNewswire 08-07 Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 08-07 Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Pr...

GlobeNewswire 08-06 Loqate names HERE Technologies foundational partner supporting address verification for e-commerce a...

GlobeNewswire 06-24 Matinas BioPharma Reports Successful Treatment of Patient with Limb-Threatening Mucor Infection in i...

GlobeNewswire 06-13 Matinas BioPharma’s Oral MAT2203 to Be Featured in Fireside Chat Hosted by A.G.P. with Antifungal Ex...

GlobeNewswire 05-16 New In Vitro Data Showing Matinas BioPharma’s LNC Platform Delivering Small Oligonucleotides Present...

GlobeNewswire 05-09 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 05-07 Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicin...

GlobeNewswire 05-07 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...

GlobeNewswire 05-02 Matinas BioPharma to Webcast Conference Call to Discuss First Quarter 2024 Financial Results and Pro...

GlobeNewswire 05-01 Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines fo...

GlobeNewswire 04-30 In Vivo Efficacy of Matinas BioPharma’s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal ...

GlobeNewswire 04-03 Matinas BioPharma Prices $10 Million Registered Direct Offering

GlobeNewswire 03-27 Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update

GlobeNewswire 03-25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

GlobeNewswire 03-22 Three Patients with Invasive Fusarium Infection in Matinas BioPharma’s Oral MAT2203 Compassionate/Ex...

GlobeNewswire 03-22 Matinas BioPharma Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire 03-06 TransCode Therapeutics To Present At 2024 RNA Leaders Europe Congress

GlobeNewswire 03-06 New Biomarker Data Add Further Evidence Supporting the Potential Benefit of SPINRAZA® (nusinersen) i...

GlobeNewswire 02-26 Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access...

GlobeNewswire 02-20 Matinas BioPharma Successfully Reaches Agreement with FDA for a Single Phase 3 Registration Trial to...

GlobeNewswire 02-08 Publicis Groupe : Full Year 2023 Results

ASOS PLC/ GB0030927254 /

If you wish to receive reply to your feedback, please provide your email address.